Check out Pro
Top Companies
Recent Trades
Cluster Buys
Sectors
Blog
Join the Insiderviz Pro waitlist
Oncocyte Corp (OCX)
All trades on this company by insiders. Hover over bubbles for specific trade details. Drag along the graph for custom price change. Green - Buy, Red - Sell, Orange - Congress Member.
Healthcare
Biotechnology
DATE
INSIDER
COMPANY
OWNED SHARES
SHARES TRADED
PRICE
NET TOTAL
BUY
14 Jun 2023
KINGSLEY ALFRED D
Director
Oncocyte Corp
(OCX)
469,111
+6%
30,000
$0.21
$6,447.00
BUY
5 Apr 2023
PURA VIDA INVESTMENTS, LLC
10% Owner
Oncocyte Corp
(OCX)
8,090,202
+8%
663,000
$0.30
$200,027.10
BUY
3 Apr 2023
BROADWOOD PARTNERS, L.P.
10% Owner
Oncocyte Corp
(OCX)
50,181,336
+114%
26,827,638
$0.30
$8,093,898.50
BUY
23 Dec 2022
Arno Andrew
Director
Oncocyte Corp
(OCX)
532,049
+88%
250,000
$0.35
$87,875.00
BUY
23 Dec 2022
Gutfreund John Peter
Director
Oncocyte Corp
(OCX)
75,000
+100%
75,000
$0.33
$24,727.50
BUY
22 Dec 2022
KINGSLEY ALFRED D
Director
Oncocyte Corp
(OCX)
439,111
+6%
25,000
$0.29
$7,125.00
BUY
17 Aug 2022
Last Andrew J.
Director
Oncocyte Corp
(OCX)
70,170
+39%
20,000
$0.87
$17,400.00
BUY
17 Aug 2022
Arno Andrew
Director
Oncocyte Corp
(OCX)
15,000
+100%
15,000
$0.90
$13,500.00
BUY
15 Aug 2022
GRIFFITH MELINDA
Director
Oncocyte Corp
(OCX)
30,000
+50%
10,000
$1.00
$10,000.00
BUY
15 Aug 2022
Carter Jennifer L.
Director
Oncocyte Corp
(OCX)
30,500
+52%
10,500
$0.95
$9,975.00
BUY
15 Aug 2022
Arno Andrew
Director
Oncocyte Corp
(OCX)
282,049
+113%
150,000
$0.96
$144,120.92
BUY
15 Aug 2022
KINGSLEY ALFRED D
Director
Oncocyte Corp
(OCX)
409,111
+2%
10,000
$0.97
$9,700.00
BUY
15 Aug 2022
Gutfreund John Peter
Director
Oncocyte Corp
(OCX)
25,000
+100%
25,000
$0.93
$23,250.00
SELL
24 Jun 2022
PURA VIDA INVESTMENTS, LLC
10% Owner
Oncocyte Corp
(OCX)
7,462,643
-1%
99,386
$1.03
$102,634.77
SELL
18 May 2022
Yu Li
VP Cntrllr/Prncpl Acctng Offcr, Officer
Oncocyte Corp
(OCX)
16,872
-32%
8,128
$1.14
$9,265.92
BUY
14 Apr 2022
PURA VIDA INVESTMENTS, LLC
10% Owner
Oncocyte Corp
(OCX)
7,350,447
+418%
5,931,707
$1.33
$7,887,849.50
BUY
13 Apr 2022
BROADWOOD PARTNERS, L.P.
10% Owner
Oncocyte Corp
(OCX)
23,353,696
+34%
6,003,752
$1.33
$7,999,999.50
BUY
25 Mar 2022
Ross Douglas T.
Chief Scientific Officer, Officer
Oncocyte Corp
(OCX)
20,317
+282%
15,000
$1.40
$21,000.00
BUY
16 Mar 2022
Redmond Cavan M.
Director
Oncocyte Corp
(OCX)
110,863
+56%
40,000
$1.19
$47,560.00
BUY
15 Mar 2022
Paulsen Gisela
Chief Operating Officer, Officer
Oncocyte Corp
(OCX)
16,500
+100%
16,500
$1.20
$19,767.00
BUY
15 Mar 2022
ANDREWS RONALD ASBURY
Chief Executive Officer, Director, Officer
Oncocyte Corp
(OCX)
293,212
+20%
50,000
$1.28
$64,150.00
BUY
15 Mar 2022
Levine Mitchell S
Chief Financial Officer, Officer
Oncocyte Corp
(OCX)
87,080
+40%
25,000
$1.17
$29,150.00
BUY
19 Mar 2021
ANDREWS RONALD ASBURY
Chief Executive Officer, Director, Officer
OncoCyte Corp
(OCX)
113,698
+10%
11,000
$4.79
$52,702.10
BUY
5 Feb 2021
BROADWOOD PARTNERS, L.P.
10% Owner
OncoCyte Corp
(OCX)
16,776,484
+3%
600,000
$4.50
$2,700,000.00
BUY
20 Jan 2021
BROADWOOD PARTNERS, L.P.
10% Owner
OncoCyte Corp
(OCX)
16,176,484
+9%
1,460,280
$3.42
$4,999,999.00
SELL
23 Dec 2020
KINGSLEY ALFRED D
Director
OncoCyte Corp
(OCX)
318,840
-0%
900
$2.55
$2,295.00
SELL
21 Dec 2020
KINGSLEY ALFRED D
Director
OncoCyte Corp
(OCX)
318,503
-11%
42,800
$0.31
$13,075.92
BUY
3 Aug 2020
Parker Albert P
Chief Operating Officer, Officer
OncoCyte Corp
(OCX)
5,000
+100%
5,000
$1.33
$6,648.00
BUY
3 Aug 2020
KALAJIAN TONY T
Sr.VP/Chief Accounting Officer, Officer
OncoCyte Corp
(OCX)
15,000
+50%
5,000
$1.31
$6,533.00
BUY
3 Aug 2020
ANDREWS RONALD ASBURY
Chief Executive Officer, Director, Officer
OncoCyte Corp
(OCX)
102,698
+63%
40,000
$1.35
$53,880.00
BUY
3 Aug 2020
Levine Mitchell S
Chief Financial Officer, Officer
OncoCyte Corp
(OCX)
36,579
+37%
10,000
$1.32
$13,200.00
BUY
24 Apr 2020
BROADWOOD PARTNERS, L.P.
10% Owner
OncoCyte Corp
(OCX)
14,716,204
+7%
1,050,000
$2.27
$2,383,500.00
BUY
30 Mar 2020
ANDREWS RONALD ASBURY
CEO and President, Director, Officer
OncoCyte Corp
(OCX)
62,698
+258%
45,216
$945.63
$42,757,452.00
SELL
2 Jan 2020
Lineage Cell Therapeutics, Inc.
Previous 10% Owner
OncoCyte Corp
(OCX)
6,041,154
-28%
2,383,090
$2.16
$5,137,942.00
BUY
2 Jan 2020
BROADWOOD PARTNERS, L.P.
10% Owner
OncoCyte Corp
(OCX)
13,043,114
+11%
1,391,466
$2.16
$3,000,000.50
BUY
13 Nov 2019
BROADWOOD PARTNERS, L.P.
10% Owner
OncoCyte Corp
(OCX)
12,274,738
+10%
1,176,471
$1.70
$2,000,000.80
BUY
17 Sep 2019
Arno Andrew
Director
OncoCyte Corp
(OCX)
102,447
+95%
50,000
$2.16
$108,130.00
BUY
13 Sep 2019
KALAJIAN TONY T
SVP-Chief Accounting Officer, Officer
OncoCyte Corp
(OCX)
10,000
+100%
10,000
$1.98
$19,800.00
BUY
12 Sep 2019
Levine Mitchell S
Chief Financial Officer, Officer
OncoCyte Corp
(OCX)
10,000
+100%
10,000
$2.01
$20,060.00
SELL
11 Sep 2019
Lineage Cell Therapeutics, Inc.
10% Owner
OncoCyte Corp
(OCX)
8,424,244
-32%
4,000,000
$1.66
$6,640,000.00
BUY
11 Sep 2019
BROADWOOD PARTNERS, L.P.
10% Owner
OncoCyte Corp
(OCX)
11,098,267
+21%
2,000,000
$1.66
$3,320,000.00
SELL
5 Jul 2019
BIOTIME INC
10% Owner
OncoCyte Corp
(OCX)
12,424,244
-15%
2,250,000
$2.00
$4,500,000.00
BUY
2 Jul 2019
BROADWOOD PARTNERS, L.P.
10% Owner
OncoCyte Corp
(OCX)
9,098,267
+12%
1,000,000
$2.00
$2,000,000.00
BUY
8 Feb 2019
BROADWOOD PARTNERS, L.P.
10% Owner
OncoCyte Corp
(OCX)
8,098,267
+7%
533,333
$3.75
$1,999,998.80
BUY
28 Mar 2018
BROADWOOD PARTNERS, L.P.
10% Owner
OncoCyte Corp
(OCX)
7,564,934
+110%
3,968,254
$1.26
$5,000,000.00
Home